Overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in hepatic and visceral adipose tissue is associated with metabolic disorders in morbidly obese patients.
BACKGROUND
The enzyme 11-beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) catalyzes intracellular glucocorticoid reactivation by conversion of cortisone to cortisol in different tissues and have been implicated in several metabolic disorders associated with obesity. The aim of this study was to evaluate the 11beta-HSD1 expression in liver, visceral adipose tissue (VAT), and subcutaneous adipose tissue (SAT) in morbidly obese patients undergoing bariatric surgery and its correlations with clinical, anthropometric, and biochemical variables.


METHODS
A prospective study was conducted over a 27-month period. Hepatic, VAT, and SAT samples were obtained at the time of surgery. 11beta-HSD1 and 18S gene expression was measured using real-time quantitative reverse transcriptase-polymerase chain reaction.


RESULTS
Forty nine patients met the inclusion criteria [mean age: 42.2 +/- 10 years, body mass index (BMI): 42 +/- 6 kg/m(2), 71% women and 63% with metabolic syndrome (MS)]. 11beta-HSD1 mRNA levels were higher in liver than fat tissue (p < 0.001), being higher in SAT than in VAT (p < 0.001) without gender-specific differences. Hepatic expression of 11beta-HSD1 correlated positively with SAT and VAT, alanine aminotransferase (ALT), and serum glucose and was inversely associated with BMI. 11beta-HSD1 mRNA in VAT correlated positively with insulinemia, ALT, and LDL cholesterol. There were no associations between 11beta-HSD1 mRNA in SAT and the variables analyzed.


CONCLUSIONS
11beta-HSD1 expression is higher in liver in comparison to adipose tissue in obese patients. The observed correlations between hepatic and VAT 11beta-HSD1 expression with dyslipidemia and insulin resistance suggest that this enzyme might have a pathogenic role in obesity and related metabolic disorders.
Baudrand
René
R
Department of Endocrinology, Faculty Of Medicine, Pontificia Universidad Católica De Chile, Lira 85, 5 Masculine Piso, Santiago, Chile.
Carvajal
Cristian A
CA
Riquelme
Arnoldo
A
Morales
Mauricio
M
Solis
Nancy
N
Pizarro
Margarita
M
Escalona
Alex
A
Boza
Camilo
C
Pérez
Gustavo
G
Domínguez
Angélica
A
Arrese
Marco
M
Fardella
Carlos E
CE
D043205:11-beta-Hydroxysteroid Dehydrogenase Type 1 / Q000378:metabolism*; D000273:Adipose Tissue / Q000201:enzymology* / Q000378:metabolism; D000328:Adult; D015992:Body Mass Index; D015897:Comorbidity; D005260:Female; D006801:Humans; D008099:Liver / Q000201:enzymology*; D008297:Male; D008659:Metabolic Diseases / Q000453:epidemiology / Q000378:metabolism; D008875:Middle Aged; D009767:Obesity, Morbid / Q000201:enzymology* / Q000453:epidemiology; D012333:RNA, Messenger / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D050151:Subcutaneous Fat / Q000201:enzymology
D012333:RNA, Messenger; D043205:11-beta-Hydroxysteroid Dehydrogenase Type 1
J Steroid Biochem Mol Biol. 1999 Apr-Jun;69(1-6):391-401
10419017
Am J Physiol Regul Integr Comp Physiol. 2005 Sep;289(3):R642-52
16105819
Vnitr Lek. 2003 Aug;49(8):656-67
14518092
Am J Gastroenterol. 2007 Feb;102(2):399-408
17311652
J Clin Endocrinol Metab. 1998 Apr;83(4):1325-35
9543163
Blood. 2005 Sep 15;106(6):2042-9
15941907
Nucleic Acids Res. 2001 May 1;29(9):e45
11328886
Diabetes. 2004 Apr;53(4):931-8
15047607
JAMA. 2001 May 16;285(19):2486-97
11368702
Diabetes. 1988 Dec;37(12):1595-607
3056758
Obesity (Silver Spring). 2006 May;14(5):794-8
16855188
Can J Physiol Pharmacol. 2006 Oct;84(10):977-84
17218963
Obesity (Silver Spring). 2007 Aug;15(8):1954-60
17712112
Scand J Clin Lab Invest. 2006;66(2):147-59
16537248
Nutr Rev. 2002 May;60(5 Pt 1):148-51
12030279
Endocr Res. 2000 Nov;26(4):711-22
11196447
Science. 2001 Dec 7;294(5549):2166-70
11739957
Endocr Rev. 2004 Oct;25(5):831-66
15466942
Mol Cell Endocrinol. 2001 Jan 22;171(1-2):15-20
11165006
Endocr Metab Immune Disord Drug Targets. 2007 Jun;7(2):125-40
17584152
Hepatology. 2005 Jun;41(6):1313-21
15915461
Niger J Med. 2004 Oct-Dec;13(4):330-5
15523856
J Clin Endocrinol Metab. 2003 Aug;88(8):3983-8
12915696
Rev Med Chil. 2005 Jun;133(6):699-706
16075135
J Clin Endocrinol Metab. 2004 Sep;89(9):4414-21
15356040
J Clin Endocrinol Metab. 2004 Sep;89(9):4755-61
15356090
Diabetes. 2004 Aug;53(8):2051-9
15277385
Ann N Y Acad Sci. 2006 Nov;1083:165-84
17148739
Am J Physiol Endocrinol Metab. 2007 Oct;293(4):E1045-52
17666487
Endocr Res. 2002 Nov;28(4):449-61
12530648
Obes Surg. 2006 Oct;16(10):1351-8
17059746
Obes Surg. 2009 Jun;19(6):764-70
18592327
Eur J Endocrinol. 2006 Sep;155(3):435-41
16914598
Obes Surg. 2006 Dec;16(12):1584-93
17217634
Lancet. 1997 Apr 26;349(9060):1210-3
9130942
Int J Obes (Lond). 2007 Dec;31(12):1826-31
17593901
Acta Cir Bras. 2006;21 Suppl 1:72-8
17013519
Proc Natl Acad Sci U S A. 2004 May 4;101(18):7088-93
15118095
Obes Surg. 2005 Sep;15(8):1148-53
16197788
Trends Endocrinol Metab. 2003 Sep;14(7):334-9
12946876
Expert Opin Investig Drugs. 2008 Apr;17(4):481-96
18363514
Circulation. 2005 Mar 22;111(11):1448-54
15781756
Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1517-28
17878220
J Clin Endocrinol Metab. 2003 Jan;88(1):285-91
12519867
World Rev Nutr Diet. 2005;94:75-83
16145253
FEBS Lett. 2004 Jul 30;571(1-3):129-33
15280030
Nihon Rinsho. 2001 Mar;59 Suppl 3:177-80
11347053
Recent Prog Horm Res. 2004;59:359-93
14749510
Rev Med Chil. 2002 Nov;130(11):1227-31
12587504
Diabet Med. 2006 May;23(5):469-80
16681555
Circulation. 2005 Oct 25;112(17):2735-52
16157765
Endocr J. 1996 Dec;43(6):645-55
9075604